Page last updated: 2024-08-23

amikacin and Extensively Drug-Resistant Tuberculosis

amikacin has been researched along with Extensively Drug-Resistant Tuberculosis in 31 studies

Research

Studies (31)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (3.23)29.6817
2010's26 (83.87)24.3611
2020's4 (12.90)2.80

Authors

AuthorsStudies
Khanna, A; Pareek, PK; Raj, VS; Rattan, A; Saini, KS; Sharma, P; Singh, H; Sood, R; Tarai, B; Upadhyay, DJ1
Dixit, PP; Thore, SN1
Bor, J; de Vos, M; Dolby, T; Horsburgh, CR; Jacobson, KR; Jenkins, HE; Leavitt, SV; Streicher, EM; Sy, KTL; Warren, RM1
Doustdar, F; Eslami, G; Ghalavand, Z; Habibnia, S; Karami-Zarandi, M; Kazemian, H; Zaker, S1
Catanzaro, A; Catanzaro, DG; Chiles, P; Ciobanu, N; Codreanu, A; Colman, RE; Cooney, CG; Crudu, V; Hillery, N; Holmberg, RC; Kukhtin, AV; Linger, Y; Norville, R; Rodwell, TC; Seifert, M; Syed, RR1
Nambiar, S; Schumann, K; Walinsky, S1
Al-Hajoj, S; Varghese, B1
Charof, R; Cherki, W; Ennassiri, W; Filali-Maltouf, A; Jaouhari, S; Lahlou, O1
Ahmed, P; Gardezi, AH; Ikram, AI; Lalani, FK; Satti, ML; Zaman, G1
Bourkadi, JE; Chaoui, I; Chetioui, F; El Mzibri, M; Elmessaoudi, MD; Karimi, H; Laglaoui, A; Oudghiri, A; Zakham, F1
Laughon, BE; Lee, SFK; Lipman, M; McHugh, TD1
Alagna, R; Besozzi, G; Castellotti, P; Cirillo, D; Codecasa, L; De Lorenzo, S; Ferrarese, M; Mazzola, E; Riccardi, N; Saderi, L; Sotgiu, G; Udwadia, Z; Viggiani, P1
Hoffner, S; Hu, Y; Jiang, W; Wu, L; Xu, B; Zhao, Q1
Chaiprasert, A; Phunpruch, S; Prammananan, T; Sowajassatakul, A1
Alkhovik, OI; Cherednichenko, AG; Dymova, MA; Filipenko, ML; Khrapov, EA; Petrenko, TI1
Fayyaz, M; Ghafoor, T; Khan, FA; Khan, KA; Mirza, IA; Satti, L1
Huang, H; Ke, Z; Liu, S; Mao, X; Shi, X; Tang, B; Wang, J1
Sibbald, B1
Cai, X; Deng, Y; Dong, H; Huan, S; Jing, H; Li, J; Li, Q; Li, X; Ou, X; Pang, Y; Su, B; Tan, Y; Xia, H; Zhang, J; Zhang, Z; Zhao, Y1
Chu, N; Duan, H; Huang, H; Jing, W; Zeng, X; Zhang, Y1
Blackmore, T; McNaughton, A; McNaughton, H1
Alland, D; Barry, CE; Chakravorty, S; Gall, A; Gao, Q; Glass, J; Jones, M; Kwiatkawoski, R; Lee, JS; Liu, X; Lokhov, S; Lund, K; Persing, D; Roh, SS; Rowneki, M; Ruan, X; Shen, Q; Shenai, S; Simmons, AM; Smith, LE; Via, LE; Viazovkina, E; Xu, P; Yuan, X; Zhang, G; Zhu, HZ1
Cho, SY; Kang, HY; Kim, CK; Kim, YJ; Lee, HJ; Oh, TS1
Alffenaar, JW; Borjas Howard, JF; Dijkstra, JA; Kosterink, JG; van Altena, R; van der Meer, ME; van der Werf, TS; van Soolingen, D1
Braker, K; Cox, HS; Feuerriegel, S; Karimovich, HA; Niemann, S; RĂ¼sch-Gerdes, S; Zarkua, N1
Amiri, M; Baghaei, P; Caminero, JA; Chitsaz, E; Farnia, P; Kazempour, M; Mansouri, D; Marjani, M; Masjedi, MR; Shamaei, M; Tabarsi, P; Velayati, AA1
Caminero, JA; Migliori, GB; Sotgiu, G; Zumla, A1
Barbedo, J; Centis, R; D'Ambrosio, L; Diogo, N; Fernandes, L; Lange, C; Migliori, GB; Raymundo, E; Sotgiu, G; Villar, M1
Barnard, M; Bosman, M; Coetzee, G; Gey Van Pittius, N; O'Brien, R; Streicher, E; van Helden, P; Warren, R1
Feng, Y; Liu, S; Lu, W; Tang, S; Wang, J; Wang, L; Wang, Q1
Banavaliker, JN; Behera, D; Bhatnagar, AK; Hanif, M; Kaushik, A; Makkar, N; Pande, JN; Porwal, C; Singh, UB; Singla, R1

Reviews

4 review(s) available for amikacin and Extensively Drug-Resistant Tuberculosis

ArticleYear
New drugs to treat difficult tuberculous and nontuberculous mycobacterial pulmonary disease.
    Current opinion in pulmonary medicine, 2019, Volume: 25, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; Clofazimine; Diarylquinolines; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Liposomes; Lung Diseases; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nitroimidazoles; Oxazoles

2019
Diagnosis of Drug Resistance to Fluoroquinolones, Amikacin, Capreomycin, Kanamycin and Ethambutol with Genotype MTBDRsl Assay: a Meta-Analysis.
    Annals of clinical and laboratory science, 2015,Fall, Volume: 45, Issue:5

    Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Genotyping Techniques; Humans; Kanamycin; Kanamycin Resistance; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant

2015
Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis.
    The Lancet. Infectious diseases, 2010, Volume: 10, Issue:9

    Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Levofloxacin; Ofloxacin; Pyrazinamide; Tuberculosis

2010
Rapid diagnosis of drug resistance to fluoroquinolones, amikacin, capreomycin, kanamycin and ethambutol using genotype MTBDRsl assay: a meta-analysis.
    PloS one, 2013, Volume: 8, Issue:2

    Topics: Amikacin; Antitubercular Agents; Area Under Curve; Capreomycin; Drug Resistance, Bacterial; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Genotype; Humans; Kanamycin; Likelihood Functions; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Odds Ratio; Sensitivity and Specificity

2013

Other Studies

27 other study(ies) available for amikacin and Extensively Drug-Resistant Tuberculosis

ArticleYear
Emergence and molecular characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates from the Delhi Region in India.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:11

    Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; DNA Gyrase; DNA Mutational Analysis; DNA-Directed RNA Polymerases; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; India; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Point Mutation; Polymerase Chain Reaction; Rifampin

2010
Hybrid triazoles: Design and synthesis as potential dual inhibitor of growth and efflux inhibition in tuberculosis.
    European journal of medicinal chemistry, 2016, Jan-01, Volume: 107

    Topics: Antitubercular Agents; Cells, Cultured; Chemistry Techniques, Synthetic; Drug Design; Drug Evaluation, Preclinical; Drug Synergism; Extensively Drug-Resistant Tuberculosis; Humans; Macrophages; Microbial Sensitivity Tests; Mycobacterium smegmatis; Mycobacterium tuberculosis; Triazoles

2016
Spatial heterogeneity of extensively drug resistant-tuberculosis in Western Cape Province, South Africa.
    Scientific reports, 2022, 06-27, Volume: 12, Issue:1

    Topics: Amikacin; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; South Africa; Tuberculosis, Multidrug-Resistant

2022
Molecular Characterization of Resistance to Second-Line Anti-Mycobacterial Drugs among Clinical Isolates of Multidrug-Resistant Mycobacterium tuberculosis.
    Clinical laboratory, 2023, Jan-01, Volume: 69, Issue:1

    Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Humans; Iran; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant

2023
Clinical Evaluation of the XDR-LFC Assay for the Molecular Detection of Isoniazid, Rifampin, Fluoroquinolone, Kanamycin, Capreomycin, and Amikacin Drug Resistance in a Prospective Cohort.
    Journal of clinical microbiology, 2023, 03-23, Volume: 61, Issue:3

    Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant

2023
FDA's Limited Population Pathway for Antibacterial and Antifungal Drugs.
    Clinical pharmacology and therapeutics, 2021, Volume: 109, Issue:4

    Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Cross Infection; Drug Approval; Drug Resistance, Microbial; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Humans; Liposomes; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Nitroimidazoles; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Sisomicin; United States; United States Food and Drug Administration

2021
First Insight Into the Fluoroquinolone and Aminoglycoside Resistance of Multidrug-Resistant
    The American journal of tropical medicine and hygiene, 2017, Volume: 96, Issue:5

    Topics: Adult; Aged; Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Female; Fluoroquinolones; Genes, Bacterial; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Molecular Typing; Moxifloxacin; Mutation; Mycobacterium tuberculosis; Retrospective Studies; Risk Factors; Saudi Arabia; Tandem Repeat Sequences; Tuberculosis, Pulmonary

2017
Extensively drug-resistant tuberculosis (XDR-TB) in Morocco.
    Journal of global antimicrobial resistance, 2017, Volume: 11

    Topics: Adolescent; Adult; Aged; Amikacin; Extensively Drug-Resistant Tuberculosis; Female; Genotype; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Morocco; Mutation; Mycobacterium tuberculosis; Ofloxacin; Young Adult

2017
Evaluation of Nitrate Reductase Assay for Early Detection of Multi and Extensively Drug Resistance Tuberculosis in our Setup.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2018, Volume: 28, Issue:1

    Topics: Amikacin; Antitubercular Agents; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Early Diagnosis; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrate Reductase; Predictive Value of Tests; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant

2018
Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco.
    BMC infectious diseases, 2018, 02-27, Volume: 18, Issue:1

    Topics: Amikacin; Antitubercular Agents; Base Sequence; Capreomycin; DNA Mutational Analysis; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Gene Frequency; Humans; Kanamycin; Microbial Sensitivity Tests; Morocco; Mutation; Mycobacterium tuberculosis; Ofloxacin; Prevalence; Tuberculosis, Multidrug-Resistant

2018
Towards tailored regimens in the treatment of drug-resistant tuberculosis: a retrospective study in two Italian reference Centres.
    BMC infectious diseases, 2019, Jun-28, Volume: 19, Issue:1

    Topics: Adult; Amikacin; Antitubercular Agents; Drug Resistance, Bacterial; Extensively Drug-Resistant Tuberculosis; Female; Humans; Italy; Laboratories, Hospital; Linezolid; Male; Meropenem; Retrospective Studies; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2019
Prevalence and genetic characterization of second-line drug-resistant and extensively drug-resistant Mycobacterium tuberculosis in Rural China.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Antitubercular Agents; Capreomycin; China; Cross-Sectional Studies; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Female; Fluoroquinolones; Genes, Bacterial; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium tuberculosis; Prevalence; Rural Population; Young Adult

2013
Molecular characterization of amikacin, kanamycin and capreomycin resistance in M/XDR-TB strains isolated in Thailand.
    BMC microbiology, 2014, Jun-22, Volume: 14

    Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Humans; Kanamycin; Mycobacterium tuberculosis; Point Mutation; Sputum; Thailand

2014
Characterization of extensively drug-resistant Mycobacterium tuberculosis isolates circulating in Siberia.
    BMC infectious diseases, 2014, Sep-03, Volume: 14

    Topics: Adult; Amikacin; Antitubercular Agents; Capreomycin; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Female; Genotype; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Minisatellite Repeats; Mutation; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Siberia; Tuberculosis; Young Adult

2014
Extensively and pre-extensively drug resistant tuberculosis in clinical isolates of multi-drug resistant tuberculosis using classical second line drugs (levofloxacin and amikacin).
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2015, Volume: 25, Issue:5

    Topics: Amikacin; Antitubercular Agents; Cross-Sectional Studies; Extensively Drug-Resistant Tuberculosis; Female; Humans; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Young Adult

2015
Drug-resistant tuberculosis plagues India.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2016, Mar-15, Volume: 188, Issue:5

    Topics: Amikacin; Antitubercular Agents; Capreomycin; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; India; Isoniazid; Kanamycin; Medication Adherence; Mycobacterium tuberculosis; Nonprescription Drugs; Rifampin; Tuberculosis, Multidrug-Resistant

2016
Rapid diagnosis of MDR and XDR tuberculosis with the MeltPro TB assay in China.
    Scientific reports, 2016, 05-06, Volume: 6

    Topics: Amikacin; China; Extensively Drug-Resistant Tuberculosis; Humans; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant

2016
Performance of the MTBDRsl Line probe assay for rapid detection of resistance to second-line anti-tuberculosis drugs and ethambutol in China.
    Diagnostic microbiology and infectious disease, 2017, Volume: 89, Issue:2

    Topics: Amikacin; Antitubercular Agents; Capreomycin; China; Drug Resistance, Multiple, Bacterial; Ethambutol; Extensively Drug-Resistant Tuberculosis; Genotype; Genotyping Techniques; Humans; Levofloxacin; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Mycobacterium tuberculosis; Sputum

2017
Comprehensive cost of treating one patient with MDR/pre-XDR-TB in Wellington, New Zealand.
    The European respiratory journal, 2016, Volume: 48, Issue:4

    Topics: Adult; Amikacin; Aminosalicylic Acid; Anti-Bacterial Agents; Antitubercular Agents; Bronchoscopy; Clofazimine; Depression; Drug Costs; Emigrants and Immigrants; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Health Care Costs; Humans; India; Isoniazid; Linezolid; Male; Mediastinum; Microbial Sensitivity Tests; Moxifloxacin; New Zealand; Pyrazinamide; Radiography, Thoracic; Rifampin; Schizophrenia, Paranoid; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pleural; Tuberculosis, Pulmonary

2016
Detection of Isoniazid-, Fluoroquinolone-, Amikacin-, and Kanamycin-Resistant Tuberculosis in an Automated, Multiplexed 10-Color Assay Suitable for Point-of-Care Use.
    Journal of clinical microbiology, 2017, Volume: 55, Issue:1

    Topics: Alleles; Amikacin; Antitubercular Agents; Automation, Laboratory; DNA, Bacterial; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Genes, Bacterial; Humans; Isoniazid; Kanamycin; Molecular Diagnostic Techniques; Mycobacterium tuberculosis; Point-of-Care Systems; Polymerase Chain Reaction; Sensitivity and Specificity

2017
RNA expression analysis of efflux pump genes in clinical isolates of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in South Korea.
    Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2017, Volume: 49

    Topics: Adenosine Triphosphatases; Amikacin; Antitubercular Agents; ATP-Binding Cassette Transporters; Bacterial Proteins; Capreomycin; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Gene Expression; Genes, Bacterial; Humans; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Sequence Analysis, DNA; Tuberculosis, Pulmonary

2017
Reduced Chance of Hearing Loss Associated with Therapeutic Drug Monitoring of Aminoglycosides in the Treatment of Multidrug-Resistant Tuberculosis.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:3

    Topics: Adult; Amikacin; Antitubercular Agents; Area Under Curve; Audiometry; Biological Availability; Drug Administration Schedule; Drug Dosage Calculations; Drug Monitoring; Extensively Drug-Resistant Tuberculosis; Female; Hearing Loss; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Retrospective Studies

2017
Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8

    Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; DNA Gyrase; Extensively Drug-Resistant Tuberculosis; Humans; Mutation; Mycobacterium tuberculosis; Ofloxacin; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant; Uzbekistan

2009
Impact of extensively drug-resistant tuberculosis on treatment outcome of multidrug-resistant tuberculosis patients with standardized regimen: report from Iran.
    Microbial drug resistance (Larchmont, N.Y.), 2010, Volume: 16, Issue:1

    Topics: Adult; Amikacin; Anti-Bacterial Agents; Clinical Protocols; Cycloserine; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Humans; Iran; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Prothionamide; Treatment Outcome; Tuberculosis, Pulmonary

2010
Linezolid safety, tolerability and efficacy to treat multidrug- and extensively drug-resistant tuberculosis.
    The European respiratory journal, 2011, Volume: 38, Issue:3

    Topics: Acetamides; Adult; Amikacin; Antitubercular Agents; Capreomycin; Drug-Related Side Effects and Adverse Reactions; Extensively Drug-Resistant Tuberculosis; Female; Fluoroquinolones; Humans; Infectious Disease Medicine; Isoniazid; Kanamycin; Linezolid; Male; Middle Aged; Oxazolidinones; Rifampin

2011
Genotype MTBDRsl line probe assay shortens time to diagnosis of extensively drug-resistant tuberculosis in a high-throughput diagnostic laboratory.
    American journal of respiratory and critical care medicine, 2012, Dec-15, Volume: 186, Issue:12

    Topics: Amikacin; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Extensively Drug-Resistant Tuberculosis; Genetic Markers; Genotype; Humans; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Mycobacterium tuberculosis; Ofloxacin; Pentosyltransferases; Rifampin; Sensitivity and Specificity; South Africa; Sputum; Time Factors

2012
Incidence and risk factors for extensively drug-resistant tuberculosis in Delhi region.
    PloS one, 2013, Volume: 8, Issue:2

    Topics: Adult; Amikacin; Antitubercular Agents; Capreomycin; Ethionamide; Extensively Drug-Resistant Tuberculosis; Female; Humans; Incidence; India; Isoniazid; Male; Mycobacterium tuberculosis; Ofloxacin; Prevalence; Rifampin; Risk Factors; Sputum; Tuberculosis, Pulmonary

2013